Baseline and early post-initiation blood eosinophil counts are associated with eosinophil-related adverse events in dupilumab-treated CRSwNP

Auris Nasus Larynx · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles